So, this exploratory study was planned to see the effect of selective serotonin reuptake inhibitors such as fluoxetine and escitalopram on various inflammatory markers such as CRP, erythrocyte sedimentation rate (ESR) and white blood cell (WBC) count and also to evaluate an association between depression and inflammatory markers. This evidence concerns the gene CRP and depressive disorder.